News

The European Commission is expected to propose a new governing framework for health data next month, called the European Health Data Space (EHDS), with the aim of connecting national health systems to facilitate secure and efficient transfer of data across systems in different European nations. The move is expected to…

A new surgical technique pioneered at the Carling Adrenal Center in Florida allows for faster recovery of adrenal gland function after removal of an adrenal tumor. The adrenal glands are a pair of small, triangular organs located above the kidneys. They are responsible for producing a number of hormones that…

The National Organization for Rare Disorders (NORD) has updated its State Report Card to make it more digitally friendly and added telehealth to its categories of rare disease policy issues in a nod to its increased use during the ongoing COVID-19 pandemic. NORD’s report card project began seven…

People with an excess of cortisol due to a benign tumor in the adrenal glands, known as an adrenal adenoma, can be more prone to bone loss even if the excess is mild, according to a Japanese study. Bone loss was more common in women and patients with a low…

A 37-year-old woman developed Cushing’s syndrome due to the rare simultaneous presence of tumors in the pituitary and adrenal glands, according to a recent case report. In these cases, “an accurate clinical, physical and endocrine examination is always recommended,” the researchers wrote. The case report, “Simultaneous pituitary and adrenal…

Cushing’s Awareness Day is April 8th — a day set aside each year to call attention to the rare disorder and the more than 6 million people who are diagnosed annually with Cushing’s disease. The day also is the birthday of Harvey Cushing, widely known as the father of…

Adult stem cells derived from the belly skin of healthy people behaved in a similar way to fat cells when challenged to grow in an environment mimicking Cushing’s syndrome, a study found. According to the study’s authors, these cells “could represent a reliable model to track the mechanisms” involved in…

Treatment with Isturisa (osilodrostat) rapidly normalized cortisol levels, eased symptoms, and improved the quality of life for people with Cushing’s disease, according to data from the Phase 3 LINC-4 trial. “Isturisa enables most patients with Cushing’s disease to gain rapid control of their cortisol levels, which in turn…

Healthcare providers involved in diagnosing and treating rare diseases believe that increased physician education and collaboration with specialized facilities will have the greatest positive impact on treating these conditions over the next five years, according to results from a 2021 survey. Definitive Healthcare, a healthcare commercial intelligence company, conducted…

Using a mouse model, scientists have found that the small molecule tubastatin A may be a potential treatment for Cushing’s disease. Tubastatin A was shown to reduce the activity of genes encoding the precursor of the adrenocorticotropic hormone (ACTH), and to lessen the growth of ACTH-producing tumor cells isolated…